- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00486395
Will CPAP Reduce Length Of Respiratory Support In Premature Infants? (OLIVIA)
Offering Less Invasive Ventilation in Infants Born 28 to 32 Weeks Gestation: A Randomized Controlled Trial.
Study Overview
Status
Intervention / Treatment
Detailed Description
Objectives: To determine whether infants 28 to 32 weeks gestational age with RDS treated with surfactant followed by CPAP have a shorter length of respiratory support (length of time on a ventilator and CPAP) than similar infants who are treated with MV after surfactant therapy; and to examine secondary outcomes including outcomes related to lung disease, feeding issues and hospital length of stay (secondary outcomes).
Hypothesis: The use of CPAP after surfactant in infants born 28 to 32 weeks with RDS will reduce the length of respiratory support as compared with infants treated with MV. We hypothesize that the incidence of lung disease and feeding issues will be similar between groups while length of hospital stay will be shorter in the CPAP group.
Methods: A multi-center, randomized trial conducted in seven neonatal intensive care units in Canada and France. Parents will be approached for consent prior to delivery or after the infant shows signs of RDS. Infants 28 to 32 weeks gestation with RDS will be eligible for the study. After intubation and surfactant administration, babies will be randomized to either receive CPAP or MV. Strict criteria for CPAP failure, weaning ventilation and weaning and discontinuing CPAP will be specified. Infants will be followed in the nursery until hospital discharge or until all outcomes have been determined.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada
- The Royal Alexandra Hspital
-
-
British Columbia
-
New Westminster, British Columbia, Canada
- The Royal Columbian Hospital
-
Surrey, British Columbia, Canada, V3L3W7
- Surrey Memorial Hospital
-
Vancouver, British Columbia, Canada, V6H3V4
- Children's and Women's Health Centre of BC
-
Victoria, British Columbia, Canada
- Victoria General Hospital
-
-
Ontario
-
Ottawa, Ontario, Canada
- The Ottawa Hospital-General Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Infants born greater than or equal to 28 weeks (28+0) and less than 32 weeks (31+6) gestation admitted to the NICU at a participating center
- Diagnosis of RDS in the first 24 hours of life requiring intubation for surfactant administration by any combination of the following: Classic clinical signs of RDS include tachypnea, moderate to severe intercostal and subcostal retractions, grunting respirations and oxygen needs of >0.30 and/or on CPAP of 5 to 6 H2O cm and/or radiographic signs of RDS including low lung volumes, a reticular-granular pattern of lung infiltrates and air bronchograms. A chest radiograph is not a mandatory criterion for the diagnosis of RDS if clinical signs are present
- Parental consent obtained.
Exclusion Criteria:
- Infants with a major congenital anomaly
- Infants with pulmonary hypoplasia; 3. Infants known or suspected to have a neuromuscular disorder;
- Infants from mothers that had greater than 2 weeks ruptured membranes.
- Infants that had vigourous resuscitation including chest compressions and cardiac meds.
- No parental consent obtained.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 2
CPAP
|
CPAP administered via "Bubble" method or Infant Flow Driver
|
Active Comparator: 1
Mechanical ventilation
|
Volume guarantee strategy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of respiratory support
Time Frame: Variable
|
CPAP plus MV days
|
Variable
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Duration of ventilation, duration of oxygen therapy, pneumothorax rate and BPD by Walsh test, time to full feeds, time to regain birthweight, necrotizing enterocolitis, time to discharge, achievement of readiness for discharge criteria
Time Frame: Variable
|
Variable
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Rebecca L Sherlock, MD, FRCPC, PhD(c), Children's and Women's Health Centre of BC
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-08 005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome, Newborn
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Dr Anna Lavizzari; Dr Francesca Gaia CiuffiniCompletedNewborn Respiratory Distress SyndromeItaly
-
Third Military Medical UniversityUnknownInfant, Newborn | RDS | Vitamin A | SurfactantChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownRespiratory Distress Syndrome of NewbornChina
-
Assiut UniversityRecruitingNeonatal Respiratory DistressEgypt
-
Groupe Hospitalier Paris Saint JosephCompletedEarly Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year (DROPE)Neonatal Respiratory Distress SyndromeFrance
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...RecruitingARDS | Respiratory Disease | Pediatric Respiratory Distress SyndromeItaly
-
University of Wisconsin, MadisonUnityPoint Health-MeriterRecruiting
-
Karolinska InstitutetCompletedRespiratory Distress Syndrome, Newborn | Infant, Newborn | Respiratory Insufficiency Syndrome of NewbornSweden
-
Unity Health TorontoRecruitingRespiratory Distress Syndrome | RDS of Prematurity | TTN | Respiratory Distress, NewbornCanada
Clinical Trials on Mechanical ventilation
-
Peking Union Medical College HospitalThe First Affiliated Hospital with Nanjing Medical University; National Natural... and other collaboratorsUnknownAcute Respiratory Failure | Immunocompromised Patients
-
Ruijin HospitalUnknownAcute Pancreatitis | Complication of Ventilation TherapyChina
-
Riphah International UniversityCompletedBurns (Physical Finding)Pakistan
-
Limin ZhuUnknownRight Ventricular Hypertrophy | Congenital Heart Disease | Postoperative Care | Mechanical Ventilation | Heart-lung InteractionChina
-
Karolinska InstitutetCompleted
-
Seoul National University HospitalCompletedVentilation | Out-Of-Hospital Cardiac Arrest | Advanced Cardiac Life SupportKorea, Republic of
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRecruitingCOVID-19 Pneumonia | COVID-19 Acute Respiratory Distress SyndromeTurkey
-
University of Milano BicoccaRecruitingAcute Brain Injury | Mechanical VentilationItaly
-
Dr. Negrin University HospitalRush University Medical CenterActive, not recruitingAcute Hypoxemic Respiratory FailureUnited States, Spain
-
Beijing Chao Yang HospitalCompletedInterstitial Lung Disease | Risk Factors | Morality | Mechanical Ventilation